Showing results (91-100 of 218) with videos related to
Sort By:
Pageof 22
Journal of Biotechnology|June 2, 2024
Enhancement of production of glycoalkaloids by elicitors along with characterization of gene expression of pathways in Solanum xanthocarpumBharat Singh, Sheenu Nathawat, Anuja Saxena, et al.International Journal of Diabetes in Developing Countries|March 26, 2010
Study of glucose uptake activity of Helicteres isora Linn. fruits in L-6 cell linesR N Gupta, Anil Pareek, Manish Suthar, et al.Clinical Lung Cancer|May 8, 2020
Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall SurvivalVamsidhar Velcheti, Sheenu Chandwani, Xin Chen, et al.Journal of Cancer Research and Therapeutics|September 26, 2025
Hypofractionated radiotherapy in carcinoma breast - A 5-year single institution experiencePardeep Garg, Navik Goyal, Sheenu Priya, et al.Phytochemistry|March 5, 2013
Fatty acids as biomarkers of microalgaeAbhishek Sahu, Imran Pancha, Deepti Jain, et al.Journal of Clinical and Diagnostic Research : JCDR|October 30, 2016
Clinical and Radiologic Evaluation of Regenerative Potential of NHA Paste and DBM in the Treatment of Periodontal Intra-bony Defects -A Randomized Control TrialDeepti Jain, Anshul Sawhney, Bharat Gupta, et al.Nanotechnology|July 19, 2022
Understanding the linear and nonlinear optical responses of few-layer exfoliated MoS2and WS2nanoflakes: experimental and simulation studiesT Abhijith, Shiju E, Rakesh Suthar, et al.Genetic Epidemiology|October 10, 2020
JEM: A joint test to estimate the effect of multiple genetic variants on DNA methylationChloé Sarnowski, Tianxiao Huan, Deepti Jain, et al.Future Oncology (London, England)|May 28, 2021
Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinomaKarthik Ramakrishnan, Zhiwen Liu, Shrujal Baxi, et al.Immunotherapy|June 12, 2019
First-line pembrolizumab monotherapy for metastatic PD-L1-positive NSCLC: real-world analysis of time on treatmentVamsidhar Velcheti, Sheenu Chandwani, Xin Chen, et al.Pageof 22